Dr. Stefan Bogusławski has been conducting research and consulting in the broad field of healthcare for almost 30 years. His professional experience includes many years of leadership at Sequence and PEX PharmaSequence – Polish advisory and research companies specializing in the healthcare market, as well as managing the Polish branch and the Central European region at IMS Health (now IQVIA) and the research company Azyx Polska. He is the author of numerous presentations at conferences in Poland and abroad, as well as publications in both general and specialized media on the Polish healthcare market, particularly the pharmaceutical market. A graduate of the Medical University of Warsaw, he obtained his medical degree in 1985. He has participated in numerous domestic and international courses and training in general management (including INSEAD), finance, marketing, communication, sales skills, and human resource management. Stefan Bogusławski also works as a senior specialist at the Department of Monitoring and Analysis of the Health Status of the Population at the National Institute of Public Health – PZH – PIB. He has been repeatedly included in the “Top 100 Most Influential People in the Polish Healthcare System” list, published by Puls Medycyny.

Co-founder of Top Consulting S.A., one of the oldest consulting companies in the Polish market. He has over 25 years of international experience in investment consulting, capital raising for companies, market acquisitions, and company management. For many years, he was a consultant for American financial organizations on Wall Street in New York, including those listed on the NASDAQ and NYSE stock exchanges. He has advised, among others: Household International in preparing acquisition strategies and obtaining a banking license in Poland, Wussler Group, Ted Turner Pictures’ partner in attempting to acquire NTV, the largest private TV station in Russia, Eiffage Construction in acquiring Mitex, the largest construction company at the time, and Industrial Union of Donbas, an industrial group in Ukraine. He has been a member, chairman, and president of the supervisory boards of numerous companies listed on the Warsaw Stock Exchange, including Bauma S.A. (now ULMA S.A.), Computerland Poland S.A. (now Signity), and PolAqua S.A. He is also a co-founder of the Start-up Hub Poland Fund. He graduated from the Faculty of Journalism and Political Science at the University of Warsaw and International Relations at the University of Hawaii in Honolulu.

A medical doctor who also completed an MBA, an effective manager. Organizer of business models and company structures – experienced in building and developing companies as well as leading corporate restructuring processes. Former director and motivator of large companies and teams. Recognized as a leader in the Polish pharmaceutical industry. Member of the Supervisory Board of American Heart of Poland SA and President of WSiP SA. Previously, President of AstraZeneca Sp. z o.o., President of Fournier Polska Sp. z o.o., Sales Director at Pfizer Polska Sp. z o.o., Sales Director and Marketing Director at MSD Poland – also involved in clinical research.